ARTICLE | Company News
Universite Laval, Microlin Bio deal
February 15, 2016 8:00 AM UTC
Microlin and the university partnered to co-develop microRNA-based therapies for Alzheimer’s disease (AD). Microlin will have exclusive, worldwide rights to develop and commercialize resulting compoun...